Table 3 Angiogenic factors relating to anti-inflammatory and immunoregulatory of EPCs
From: Anti-inflammatory Prowess of endothelial progenitor cells in the realm of biology and medicine
Factor | EPC phenotype | Effect on inflammation and immunity | Involved pathway | Refs. |
---|---|---|---|---|
VEGF | CD34+/CD133+ | ↓ inflammation | ↓ TLR4-NF-κB and PI3K-Akt | |
TGF-β | CD34+/CD133+ | ↓pro-inflammatory cytokine ↑ M2 and Treg ↓Th17 | Unknown | |
FGF | ECFCs | ↓IL-1, TNF-α, IL-6, and MCP-1 ↓CD40 | ERK1/2 NF-κB2 | |
G-CSF/GM-CSF | CD34+/CD133+ | ↑ CD103+ DCs ↑M2, Th2 and Treg ↓TNF-α and IL-1β ↓T cell recruitment | Unknown Epigenetic modifications | |
HGF | ECFCs | ↑ IL-1Ra ↓TNF-α, IL-6, and IL-1β ↑CD14+ and IL-10 ↓CD4+ ↑ Th2 | NF-κB ERK1/2 | |
PDGF | ECFCs | ↑IL-4, IL-10, and IL-13 ↓MMP-3, MMP-13, COX-2, IL-1, IL-6, and TNF- α ↑ M2 and Treg | NF-κB p65 translocation PI3K/Akt-MEK/ERK |